Why Quill?
Where Science Meets Story
Modern medicine wouldn’t exist without the written word. From early herbal remedies to today’s targeted biologics, every breakthrough has relied on work done before—and lays the ground for what comes next.
Just as the quill gave voice to centuries of discovery, Quill Science uses words to shape the future of medicine by fusing science, strategy, and storytelling.
Meet the founder
Christopher Pratt, PhD
Founder & President
Chris is an accomplished scientist and communicator with over 12 years of academic research experience, 3 years of in-house agency experience, and over 3 years of operating a business.
Chris has led scientific communications strategy for some of the most trusted names in the industry—Pfizer, Takeda, Abbvie, Blueprint Medicines, and Sunovion (now Sumitomo Pharma America) to name a few—and brings scientific accuracy, creativity, and credibility to every client partnership.
Known for blending academic rigor with emotional intelligence, Chris is trusted by teams across biotech and pharma for his rare ability to help audiences connect with the science with precision, clarity, and heart.
Let’s work together to elevate scientific and medical advances with clear and compelling messages.
Statement on Quill Science’s Use of Artificial Intelligence (AI)
Quill Science uses AI-assisted medical writing ethically and responsibly to work more efficiently and provide our clients with more value.
We customize information from AI to client and audience needs by using information about the client’s needs, perspectives, insights, and strategies.
All AI outputs are vetted for accuracy, and proprietary information is never shared with any AI model.